Rapid Eye Movement (REM) sleep behaviour disorder (RBD) is an early biomarker of neurodegeneration but requires resource-intensive video-polysomnography (v-PSG) for diagnosis. This study presents an interpretable pipeline for automated detection of idiopathic RBD (iRBD) using heart rate variability (HRV) features extracted from ECG during sleep. HRV metrics are computed separately for each sleep stage to capture stage-specific autonomic signatures. Selected features are used to train an Explainable Boosting Machine (EBM). The approach is evaluated on an age-matched cohort of 67 subjects (33 healthy controls and 34 iRBD) using nested LeaveOne-Subject-Out cross-validation. Across ten random seeds, the REM stage yielded the best performance (AUC = 0.82 ± 0.02, accuracy = 0.75 ± 0.04). Four HRV features are consistently selected across folds, indicating stable autonomic markers of iRBD and highlighting the potential of single-lead ECG as a scalable screening tool.

Interpretable HRV-Based Detection of REM Sleep Behaviour Disorder via Explainable Boosting Machines / Digiacomo, F., Mosca, U., Ciampa, I., Rechichi, I., Cicolin, A., Olmo, G.. - (2026), pp. 1096-1101. (39th IEEE International Symposium on Computer-Based Medical Systems, CBMS 2026 Limassol (CY) June 3-5 2026) [10.1109/CBMS69103.2026.00223].

Interpretable HRV-Based Detection of REM Sleep Behaviour Disorder via Explainable Boosting Machines

Digiacomo, Federico;Mosca, Umberto;Ciampa, Ilaria;Rechichi, Irene;Olmo, Gabriella
2026

Abstract

Rapid Eye Movement (REM) sleep behaviour disorder (RBD) is an early biomarker of neurodegeneration but requires resource-intensive video-polysomnography (v-PSG) for diagnosis. This study presents an interpretable pipeline for automated detection of idiopathic RBD (iRBD) using heart rate variability (HRV) features extracted from ECG during sleep. HRV metrics are computed separately for each sleep stage to capture stage-specific autonomic signatures. Selected features are used to train an Explainable Boosting Machine (EBM). The approach is evaluated on an age-matched cohort of 67 subjects (33 healthy controls and 34 iRBD) using nested LeaveOne-Subject-Out cross-validation. Across ten random seeds, the REM stage yielded the best performance (AUC = 0.82 ± 0.02, accuracy = 0.75 ± 0.04). Four HRV features are consistently selected across folds, indicating stable autonomic markers of iRBD and highlighting the potential of single-lead ECG as a scalable screening tool.
File in questo prodotto:
File Dimensione Formato  
499901b096.pdf

accesso riservato

Tipologia: 2a Post-print versione editoriale / Version of Record
Licenza: Non Pubblico - Accesso privato/ristretto
Dimensione 755.4 kB
Formato Adobe PDF
755.4 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
2026191731.pdf

accesso aperto

Tipologia: 2. Post-print / Author's Accepted Manuscript
Licenza: Pubblico - Tutti i diritti riservati
Dimensione 893.62 kB
Formato Adobe PDF
893.62 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11583/3016270